Publications

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

 93
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Next Article

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

PDIA3 defines a novel subset of adipose macrophages to exacerbate the development of obesity and metabolic disorders

PDIA3 defines a novel subset of adipose macrophages to ...

 70

Cannabinoid Hyperemesis Syndrome

Cannabinoid Hyperemesis Syndrome

 52

Hypoxia ameliorates neurodegeneration and movement disorder in a mouse model of Parkinson’s disease

Hypoxia ameliorates neurodegeneration and movement diso...

 79